Next Article in Journal
Immune Responses to SARS-CoV-2 Infection and Vaccine in a Big Italian COVID-19 Hospital: An 18-Month Follow-Up
Next Article in Special Issue
From Co-Administration to Co-Formulation: The Race for New Vaccines against COVID-19 and Other Respiratory Viruses
Previous Article in Journal
COVID-19 Risk Perception and Adherence to Preventive Measures among Medical Students after Receiving COVID-19 Vaccination: A Multicenter Cross-Sectional Study in Egypt
Previous Article in Special Issue
Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination
 
 
vaccines-logo
Article Menu

Article Menu

Article
Peer-Review Record

Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report

by Jason D. Goldman 1,2,3, Kai Wang 4, Katharina Röltgen 5, Sandra C. A. Nielsen 5, Jared C. Roach 4,*, Samia N. Naccache 6, Fan Yang 5, Oliver F. Wirz 5, Kathryn E. Yost 5, Ji-Yeun Lee 5, Kelly Chun 7, Terri Wrin 8, Christos J. Petropoulos 8, Inyoul Lee 4, Shannon Fallen 4, Paula M. Manner 2,9, Julie A. Wallick 2,9, Heather A. Algren 2,9, Kim M. Murray 4, Jennifer Hadlock 2,4, Daniel Chen 4, Chengzhen L. Dai 4, Dan Yuan 4, Yapeng Su 4, Joshua Jeharajah 10, William R. Berrington 1,2, George P. Pappas 11, Sonam T. Nyatsatsang 1,2, Alexander L. Greninger 12,13, Ansuman T. Satpathy 5, John S. Pauk 1,2, Scott D. Boyd 5,14 and James R. Heath 4add Show full author list remove Hide full author list
Reviewer 1:
Reviewer 2: Anonymous
Submission received: 17 November 2022 / Revised: 15 December 2022 / Accepted: 15 December 2022 / Published: 20 December 2022
(This article belongs to the Special Issue Immune Response of SARS-CoV-2 Infection)

Round 1

Reviewer 1 Report

The manuscript of Goldman et al. describes an in-depth study of a single patient apparently re-infected with a different SARS-CoV2 strain after recovering from the first infection. The study is scientifically sound and well-presented but has two or even three major issues that should be resolved prior to publication: 1) Supplementary Figures and Methods are unavailable on the journal website, the file with the same exact Figures as within the manuscript is uploaded instead, therefore full data review is impossible; 2) Authors have to address and explain, at least in the Discussion (in addition to Conclusions), why this manuscript is submitted more than two years after the fact and to correct statements made in Discussion with respect to 2+ years of SARS-CoV research post-dating their results (otherwise Discussion looks really obsolete and not at all helpful). Additionally, using the words "Failure of Humoral Immunity" in the title of the manuscript (notably, not in the Abstract) is too strong a statement for this reviewer, it should be definitely amended, especially in light of the patient having much weaker disease on the re-exposure and also presenting certain (albeit not all) immune correlates of protection.

Minor comments relate to a few typos: 1) The name of 'Shannon Fallen and BS' in the authors' list should probably be just 'Shannon Fallen'; 2) The reference 20 (line 89), if this is actually it, is not properly formatted; 3) 'Plasma cytokines levels' (line 94) should be 'Plasma cytokine levels'; 4) The word 'patient' is missing from the sentence in lines 133-134 (should be 'and THE PATIENT was treated').

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

COVID-19 continues to be an evolving disease, with the emergence of a number of SARS-CoV-2 genetic variants impacting the efficacy of currently approved COVID-19 vaccines. Research is needed to understand the host immune response to viral variants, the kinetics of neutralizing antibodies, and correlates of immunity associated with SARS-CoV-2 reinfection. In this manuscript, Goldman et al. provide a very thorough genetic and immunological investigation of a documented case of reinfection with SARS-CoV-2. The authors used whole-genome sequencing to compare the viruses of the initial and reinfection cases and analyzed antibody production, B cells, and T cell phenotypes to provide insight into correlates of adaptive immunity from reinfection. While this study has the limitations inherent in case reports (i.e., a very small sample size and in this case, one patient), the authors provide valuable information on the antibody, B cell, and T cell analytics associated with this case of SARS-CoV-2 reinfection. This case report is very interesting, exceedingly well-written, and provides important information on the immunological characteristics of reinfection. I could not find any major or minor issues that need to be addressed by the authors prior to publication.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop